Brief: AFT Pharmaceuticals Provides March Quarter Investor Update
07/04/2026 03:11
April 7 (Reuters) - AFT Pharmaceuticals Ltd AFT.NZ: MARCH QUARTER FY 2026 INVESTOR UPDATE FY26 OPERATING EARNINGS GUIDANCE NZ$20-NZ$24 MILLION Further company coverage: AFT.NZ ((Reuters.Briefs@thomsonreuters.com;))
Recent news on AFT Pharmaceuticals
See all newsNZ's AFT Pharma eyes highest weekly gain in over 2 months after results
Brief: AFT Pharmaceuticals Reports Double Digit Revenue Growth In 1H FY27
NZ's AFT Pharmaceuticals gains most in over 2 weeks on strong half-year results
Brief: AFT Pharmaceuticals Enters Exclusive Development, License And Supply Agreement With Mikasaseiyaku
NZ's AFT Pharma rises to near 1-month high on Japan licensing deal for Maxigesic IV